Award

BH_NonClinical_Pharmacy_Car-T

BARTS HEALTH NHS TRUST

This public procurement record has 1 release in its history.

Award

26 Nov 2025 at 09:46

Summary of the contracting process

Barts Health NHS Trust, located in London, has completed a procurement process for the provision of CAR-T therapy products, a cutting-edge personalised immunotherapy treatment to fight cancer. The contract is under the industry category of medical equipment, pharmaceuticals, and pharmacy services, and it was directly awarded to Bristol Myers Squibb due to their unique capabilities in this area. The contract, which has a start date of 8th December 2025, will have an initial duration of five years with an option to extend for an additional five years. There are no minimum order commitments, and prices are capped at those approved by NICE/NHS England.

This tender presents substantial business growth opportunities, especially for enterprises specialising in medical innovations and pharmaceuticals. Large suppliers with capacity to provide sophisticated medical treatments like CAR-T therapy may find this contract with the public healthcare sector advantageous in establishing long-term partnerships. Given the exclusive supplier arrangements owing to the intellectual property considerations, businesses possessing similar exclusive capabilities can leverage such procurement opportunities to expand their footprint within the UK's healthcare market.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

BH_NonClinical_Pharmacy_Car-T

Notice Description

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.

Procurement Information

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells. The products can only be supplied by the the proposed contractor, Bristol Myers Squibb.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05e8d3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/077086-2025
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

85 - Health and social work services


CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

85149000 - Pharmacy services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£2,100,000 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
26 Nov 20252 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
26 Nov 20252 months ago
Contract Period
8 Dec 2025 - 5 Dec 2030 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
BARTS HEALTH NHS TRUST
Contact Name
Not specified
Contact Email
oliver.watling@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
E14 5HJ
Post Town
East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified

Local Authority
Tower Hamlets
Electoral Ward
Blackwall & Cubitt Town
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

BRISTOL MYERS SQUIBB

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-05e8d3-2025-11-26T09:46:27Z",
    "date": "2025-11-26T09:46:27Z",
    "ocid": "ocds-h6vhtk-05e8d3",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PVTL-5832-LMDG",
            "name": "Barts Health NHS Trust",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PVTL-5832-LMDG"
            },
            "address": {
                "streetAddress": "20 Churchill Place, Canary Wharf",
                "locality": "London",
                "postalCode": "E14 5HJ",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI42"
            },
            "contactPoint": {
                "email": "oliver.watling@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.bartshealth.nhs.uk",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    }
                ]
            }
        },
        {
            "id": "GB-COH-02487574",
            "name": "Bristol Myers Squibb",
            "identifier": {
                "scheme": "GB-COH",
                "id": "02487574"
            },
            "address": {
                "streetAddress": "Arc Uxbridge Sanderson Road, New Denham,",
                "locality": "Denham",
                "postalCode": "UB8 1DH",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKJ13"
            },
            "contactPoint": {
                "email": "jon.joyce@bms.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "vcse": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PVTL-5832-LMDG",
        "name": "Barts Health NHS Trust"
    },
    "tender": {
        "id": "C402343",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "BH_NonClinical_Pharmacy_Car-T",
        "description": "CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient's T cells are genetically modified to target cancer cells. The products can only be supplied by the the proposed contractor, Bristol Myers Squibb.",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersIntellectualPropertyExclusiveRights"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Provision of CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) products",
            "status": "pending",
            "value": {
                "amountGross": 2520000,
                "amount": 2100000,
                "currency": "GBP"
            },
            "mainProcurementCategory": "services",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-COH-02487574",
                    "name": "Bristol Myers Squibb"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33000000",
                            "description": "Medical equipments, pharmaceuticals and personal care products"
                        },
                        {
                            "scheme": "CPV",
                            "id": "85149000",
                            "description": "Pharmacy services"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2025-12-08T00:00:00Z",
                "endDate": "2030-12-05T23:59:59Z",
                "maxExtentDate": "2035-12-07T23:59:59Z"
            },
            "hasRenewal": true,
            "renewal": {
                "description": "Option to extend contract by a further 5 years"
            },
            "hasOptions": true,
            "options": {
                "description": "Extension option"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "077086-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/077086-2025",
                    "datePublished": "2025-11-26T09:46:27Z",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2025-12-08T23:59:59Z",
                    "status": "scheduled"
                }
            ]
        }
    ],
    "language": "en"
}